RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Sean Dodge maintains an Outperform rating on HealthEquity (HQY) and raises the price target from $77 to $90.
February 23, 2024 | 4:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital analyst Sean Dodge maintains an Outperform rating on HealthEquity and raises the price target from $77 to $90.
The increase in price target by a reputable analyst suggests a positive outlook on the company's future performance, likely leading to increased investor confidence and potentially driving the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100